Skip to content
Est. 1998 proudly celebrating 27 years of standing behind American companies
American Origin Unverified This profile is unclaimed and has not been independently reviewed. Claim & get verified

Lantheus Holdings, Inc. (LNTH)

$100.15 +0.23% NASDAQ: LNTH · 15-min delayed
  • NORTH BILLERICA, Massachusetts
  • Public · NASDAQ: LNTH
  • 1,193 employees
$6.8BMarket cap
$1.5BRevenue · FY2025
$233.6MNet income
1,193Employees
LNTHNASDAQ
2015IPO

About Lantheus Holdings, Inc.

Lantheus Holdings Inc is a radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight and Follow disease to deliver patient outcomes. The Company classifies its products into Radiopharmaceutical Oncology, Precision Diagnostics, and Strategic Partnerships and Other Revenue. Its products help healthcare professionals Find, Fight and Follow cancer and diseases and are used by physicians and technologists in clinical settings. The Company produces and markets its products in the United States, mainly to hospitals, independent imaging centers and government facilities, and sells outside the United States through direct and third-party distribution relationships and licensing arrangements in Europe, Canada, Australia, Asia-Pacific, Central America and South America.

This profile is unclaimed. An authorized representative can claim it free to control the page and activate the embeddable Verified badge.

Reported figures

Financial summary

Revenue FY2025
$1.5B
Net income
$233.6M
Total assets
$2.2B
Market cap
$6.8B

Source: SEC EDGAR · updated Jun 7, 2026

NASDAQ: LNTH
$100.15 +0.23%

15-minute delayed · data by Polygon.io

Past year · hover for prices

$50.61 $110.94

52-week range

Market cap
$6.8B
Shares outstanding
68.1M
Open
—
Day range
–
Prev close
—
Volume
—
IPO date
Jun 25, 2015

Lantheus Holdings, Inc. (LNTH) Stock Price

  • Profitable — net income of $233.6M in FY2025.
  • Trading 10% below its 52-week high.

Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.

No reviews yet. Be the first to review Lantheus Holdings, Inc..

Write a review
Newsroom

News about Lantheus Holdings, Inc.

News & sentiment via Polygon.io

FAQ

Lantheus Holdings, Inc.: frequently asked questions

Is Lantheus Holdings, Inc. an American company?

Lantheus Holdings, Inc. is a US-based company headquartered in North Billerica, Massachusetts, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.

Where is Lantheus Holdings, Inc. headquartered?

Lantheus Holdings, Inc. is headquartered in North Billerica, Massachusetts, United States.

Is Lantheus Holdings, Inc. publicly traded?

Yes — Lantheus Holdings, Inc. is a publicly traded company. Its stock trades under the ticker symbol LNTH on the NASDAQ.

What does Lantheus Holdings, Inc. do?

Lantheus Holdings, Inc. is an American Medical Devices company in the Health & Beauty sector.

Explore

Similar companies

Browse all →